BibTex format
@article{Dobra:2024:10.1016/j.prrv.2024.08.001,
author = {Dobra, R and Carroll, S and Davies, JC and Dowdall, F and Duff, A and Elderton, A and Georgiopoulos, AM and Massey-Chase, R and McNally, P and Puckey, M and Madge, S},
doi = {10.1016/j.prrv.2024.08.001},
journal = {Paediatr Respir Rev},
title = {Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges.},
url = {http://dx.doi.org/10.1016/j.prrv.2024.08.001},
year = {2024}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - Cystic fibrosis (CF) is traditionally associated with considerable and progressive multisystem pathology, onerous treatment burden, complex psychosocial challenges, and reduced life-expectancy [1-9].This decade has seen transformative change in management for many, but not all, people with CF. The most notable change comes from Cystic Fibrosis Transmembrane Receptor (CFTR) modulators, which bring significant benefits for people who are eligible for, and able to access, them [10]. However alongside, or perhaps because of, this exciting progress, the past few years have also brought important novel challenges to the psychosocial wellbeing of people with CF. This article, written as a collaboration between CF psychologists, social workers, physicians and nurses aims to provide an accessible overview of the novel psychosocial challenges now faced by children, their families, and adults with CF, and to invite consideration of their changing psychosocial requirements to inform future holistic care. Themes include geopolitical stressors such as the pandemic and its wake, a growing divide between those able or unable to access CFTR modulators, potential rapid changes in life expectancy secondary to these drugs and the inevitable associated challenges this brings; evolving body image, mental health side effects of CFTR modulators, the challenges of adherence in apparently well children and young adults, as well as the diagnostic conundrum and associated anxiety of the cystic fibrosis screen positive inconclusive diagnosis (CFSPID) label. It also highlights some unmet research and service delivery needs in the area.
AU - Dobra,R
AU - Carroll,S
AU - Davies,JC
AU - Dowdall,F
AU - Duff,A
AU - Elderton,A
AU - Georgiopoulos,AM
AU - Massey-Chase,R
AU - McNally,P
AU - Puckey,M
AU - Madge,S
DO - 10.1016/j.prrv.2024.08.001
PY - 2024///
TI - Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges.
T2 - Paediatr Respir Rev
UR - http://dx.doi.org/10.1016/j.prrv.2024.08.001
UR - https://www.ncbi.nlm.nih.gov/pubmed/39261143
ER -